• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用超薄支架药物洗脱支架的T型及突出技术的长期临床和血管造影结果

Long-term clinical and angiographic outcome of T-and protrusion technique with ultrathin strut drug eluting stents.

作者信息

Dézsi Csaba A, Andréka Judit, Sayour Amer M, Deák Mónika, Szentes Veronika, Sebők Zoltán, Fi Zsolt, Achim Alexandru, Ruzsa Zoltán

机构信息

Faculty of Health and Sports Sciences, Department of Health, and Nursing Sciences, Széchenyi István University, Győr, Hungary.

Department of Cardiology, Győr-Moson-Sopron County Petz A. University Teaching Hospital, Győr, Hungary.

出版信息

Future Cardiol. 2024 Dec-Dec;20(15-16):837-842. doi: 10.1080/14796678.2024.2435205. Epub 2024 Dec 4.

DOI:10.1080/14796678.2024.2435205
PMID:39630015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11731050/
Abstract

OBJECTIVES

Data about coronary bifurcations treated with ultrathin strut drug-eluting stents (DES) using T-and-protrusion (TAP) technique is limited.

METHODS

In this study, a total of 84 consecutive patients, who underwent bifurcation percutaneous coronary intervention (PCI) with TAP technique using Orsiro® DES (Biotronik, Berlin, Germany), were included. All pre- and post-procedural data, as well as 1- and 2-year follow-up angiograms, were analyzed. Primary endpoints were procedural success and target lesion failure (TLF); secondary endpoints were all-cause mortality and major adverse cardiac and cerebrovascular events (MACCE) during follow-up.

RESULTS

Procedural success was achieved in 100% of cases. TLF rate was higher in patients presented with acute coronary syndrome compared to the ones with chronic coronary syndrome (19% vs. 5%  = 0.09). All-cause mortality was 30% during follow-up, from which 26% was due to non-cardiovascular cause, and the MACCE rate was 46%.

CONCLUSIONS

Coronary bifurcations treated with ultrathin strut DES showed good short-term results and were associated with acceptable cardiovascular mortality. However, in these long-term patients, the rate of MACCE and non-cardiovascular death were rather high.

摘要

目的

关于使用T型和突出型(TAP)技术的超薄支架药物洗脱支架(DES)治疗冠状动脉分叉病变的数据有限。

方法

在本研究中,纳入了总共84例连续患者,他们使用Orsiro® DES(德国柏林百多力公司)通过TAP技术接受了分叉经皮冠状动脉介入治疗(PCI)。分析了所有术前和术后数据以及1年和2年的随访血管造影图像。主要终点是手术成功率和靶病变失败(TLF);次要终点是随访期间的全因死亡率和主要不良心脑血管事件(MACCE)。

结果

100%的病例实现了手术成功。与慢性冠状动脉综合征患者相比,急性冠状动脉综合征患者的TLF率更高(19%对5% = 0.09)。随访期间全因死亡率为30%,其中26%是由于非心血管原因,MACCE率为46%。

结论

使用超薄支架DES治疗的冠状动脉分叉病变显示出良好的短期结果,并且与可接受的心血管死亡率相关。然而,在这些长期患者中,MACCE和非心血管死亡的发生率相当高。

相似文献

1
Long-term clinical and angiographic outcome of T-and protrusion technique with ultrathin strut drug eluting stents.采用超薄支架药物洗脱支架的T型及突出技术的长期临床和血管造影结果
Future Cardiol. 2024 Dec-Dec;20(15-16):837-842. doi: 10.1080/14796678.2024.2435205. Epub 2024 Dec 4.
2
Long-term safety and efficacy of self-apposing Stentys drug-eluting stent in left main stem percutaneous coronary intervention: final results of multicentre LM-STENTYS registry.自贴式Stentys药物洗脱支架在左主干经皮冠状动脉介入治疗中的长期安全性和有效性:多中心LM-STENTYS注册研究的最终结果
Cardiol J. 2025;32(3):239-247. doi: 10.5603/cj.101925. Epub 2025 May 30.
3
Long-term safety of ultrathin bioabsorbable-polymer sirolimus-eluting stents versus thin durable-polymer drug-eluting stents in acute coronary syndrome: A systematic review and meta-analysis.超薄生物可吸收聚合物西罗莫司洗脱支架与薄型持久聚合物药物洗脱支架治疗急性冠状动脉综合征的长期安全性:系统评价和荟萃分析。
Clin Cardiol. 2023 Dec;46(12):1465-1473. doi: 10.1002/clc.24139. Epub 2023 Sep 3.
4
Treatment of in-stent restenosis with ultrathin-strut versus thin-strut drug-eluting stents or drug-eluting balloons: a multicentre registry.采用超薄支架与薄支架药物洗脱支架或药物洗脱球囊治疗支架内再狭窄:一项多中心注册研究。
EuroIntervention. 2024 Nov 4;20(21):e1340-e1354. doi: 10.4244/EIJ-D-24-00491.
5
Drug-eluting stents versus bare-metal stents for acute coronary syndrome.药物洗脱支架与裸金属支架治疗急性冠状动脉综合征的比较
Cochrane Database Syst Rev. 2017 Aug 23;8(8):CD012481. doi: 10.1002/14651858.CD012481.pub2.
6
Target Lesion Failure With Current Drug-Eluting Stents: Evidence From a Comprehensive Network Meta-Analysis.当前药物洗脱支架的靶病变失败:来自综合网络荟萃分析的证据。
JACC Cardiovasc Interv. 2020 Dec 28;13(24):2868-2878. doi: 10.1016/j.jcin.2020.09.014.
7
FFR-Guided Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Diabetes.糖尿病患者中,基于血流储备分数(FFR)指导的经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较
JAMA Cardiol. 2025 Jun 1;10(6):603-608. doi: 10.1001/jamacardio.2025.0095.
8
Impact of Target Lesion Revascularization on Long-Term Mortality After Percutaneous Coronary Intervention for Left Main Disease.左主干病变经皮冠状动脉介入治疗后靶病变血运重建对长期死亡率的影响。
JACC Cardiovasc Interv. 2024 Jan 8;17(1):32-42. doi: 10.1016/j.jcin.2023.10.068.
9
Predictors and Long-Term Prognostic Significance of Bailout Stenting During Percutaneous Coronary Interventions With Sirolimus-Coated Balloon: A Subanalysis of the Eastbourne Study.西罗莫司涂层球囊经皮冠状动脉介入治疗中补救性支架置入的预测因素及长期预后意义:伊斯特本研究的亚组分析
Am J Cardiol. 2025 Mar 15;239:68-74. doi: 10.1016/j.amjcard.2024.12.015. Epub 2024 Dec 16.
10
Stepwise Provisional Versus Systematic Dual-Stent Strategies for Treatment of True Left Main Coronary Bifurcation Lesions.治疗真性左主干冠状动脉分叉病变的逐步临时与系统性双支架策略
Circulation. 2025 Mar 4;151(9):612-622. doi: 10.1161/CIRCULATIONAHA.124.071153. Epub 2025 Feb 5.

本文引用的文献

1
Stepwise provisional versus systematic culotte for stenting of true coronary bifurcation lesions: five-year follow-up of the multicentre randomised EBC TWO Trial.真性冠状动脉分叉病变支架置入的逐步临时支架术与系统性裤裙支架术对比:多中心随机EBC TWO试验的五年随访
EuroIntervention. 2023 May 16;19(4):e297-304. doi: 10.4244/EIJ-D-23-00211.
2
Long-term outcomes with biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in ST-segment elevation myocardial infarction: 5-year follow-up of the BIOSTEMI randomised superiority trial.生物可降解聚合物西罗莫司洗脱支架与持久性聚合物依维莫司洗脱支架治疗 ST 段抬高型心肌梗死的长期疗效:BIOSTEMI 随机优势试验 5 年随访结果。
Lancet. 2023 Nov 25;402(10416):1979-1990. doi: 10.1016/S0140-6736(23)02197-9. Epub 2023 Oct 25.
3
High Non-Cardiac Death Incidence Should Be a Limitation of Drug-Eluting Stents Implantation? Insights from Recent Randomized Data.高非心脏性死亡发生率应成为药物洗脱支架植入的限制因素吗?来自近期随机数据的见解。
Diagnostics (Basel). 2023 Apr 2;13(7):1321. doi: 10.3390/diagnostics13071321.
4
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club.冠状动脉分叉病变的治疗,第二部分:植入两枚支架。欧洲分叉俱乐部第 16 次专家共识文件。
EuroIntervention. 2022 Aug 19;18(6):457-470. doi: 10.4244/EIJ-D-22-00166.
5
Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club.冠状动脉分叉病变的治疗,第一部分:在临时通道中植入第一个支架。欧洲分叉俱乐部第 16 个专家共识文件。
EuroIntervention. 2022 Aug 5;18(5):e362-e376. doi: 10.4244/EIJ-D-22-00165.
6
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021年美国心脏病学会/美国心脏协会/心血管造影和介入学会冠状动脉血运重建指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 Jan 18;145(3):e18-e114. doi: 10.1161/CIR.0000000000001038. Epub 2021 Dec 9.
7
Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial.多中心、随机对照研究:复杂冠状动脉分叉病变患者中双支架技术与临时支架置入技术的比较——DEFINITION II试验
Eur Heart J. 2020 Jul 14;41(27):2523-2536. doi: 10.1093/eurheartj/ehaa543.
8
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5-year outcomes of the BIOSCIENCE randomised trial.超薄支架、可生物降解聚合物、西罗莫司洗脱支架与薄支架、耐用聚合物、依维莫司洗脱支架经皮冠状动脉血运重建:BIOSCIENCE 随机试验 5 年结果。
Lancet. 2018 Sep 1;392(10149):737-746. doi: 10.1016/S0140-6736(18)31715-X. Epub 2018 Aug 28.
9
Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study.冠状动脉分叉病变单纯支架置入术与复杂支架置入术治疗:来自北欧分叉病变研究和英国分叉冠状动脉研究的患者水平汇总分析的 5 年生存结果。
Eur Heart J. 2016 Jun 21;37(24):1923-8. doi: 10.1093/eurheartj/ehw170. Epub 2016 May 8.
10
Technical aspects of the T And small Protrusion (TAP) technique.
EuroIntervention. 2015;11 Suppl V:V91-5. doi: 10.4244/EIJV11SVA20.